Je. Matthews et al., PHARMACOLOGICAL CHARACTERIZATION AND SELECTIVITY OF THE NPY ANTAGONIST GR231118 (1229U91) FOR DIFFERENT NPY RECEPTORS, Regulatory peptides, 72(2-3), 1997, pp. 113-119
Neuropeptide Y (NPY) is widely distributed throughout the central and
peripheral nervous system and exerts a wide range of physiological res
ponses by activating specific receptors. In this study we have charact
erized the potency of the high affinity peptide dimer antagonist, GR23
1118, to displace radiolabeled NPY/PYY from different tissues and cell
lines expressing Y1 or Y2 receptors and from CHO cells stably transfe
cted with human cDNA encoding for Y1, Y2 and Y4 receptors. GR231118 di
splays high affinity for Y1 and Y4 receptors, equal or better than tha
t of NPY itself, while its activity is several fold weaker for Y2 rece
ptors. Displacement of radiolabeled PYY from rat hypothalamic membrane
s by GR231118, reveals the existence of high and low affinity binding
sites which may be equated to Y1 and Y2 receptors respectively suggest
ing that the compound maybe used as a tool to dissect central NPY rece
ptors. (C) 1997 Elsevier Science B.V.